Trial intelligence / Profile preview

Fludarabine with Methotrexate for Severe Rheumatoid Arthritis

NCT00001677Phase 2Completed

Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Start
Jun 1998
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of fludarabine in rheumatoid arthritis (RA), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Jun 1998; status: completed.

02

Drugs

fludarabine
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00001677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call